Results 41 to 50 of about 331 (121)
EGFR‐KDD Myofibroblastic Neoplasm or Congenital Peribronchial Myofibroblastic Tumor (CPMT)? Report of a Congenital Myofibroblastic Neoplasm With Unusual Histologic Features
Genes, Chromosomes and Cancer, Volume 64, Issue 4, April 2025.ABSTRACT
EGFR‐kinase‐domain duplication (KDD) has been reported in Infantile fibrosarcoma‐like myofibroblastic tumors and cellular mesoblastic nephroma. We report a pulmonary neoplasm with EGFR‐(KDD) and infantile fibrosarcoma‐like histologic features in a female infant with an unusual clinical and histologic evolution, characterized by persistent ...Emma Rullo, Sabina Barresi, Sabrina Rossi, Sara Patrizi, Evelina Miele, Marta Barisella, Michela Casanova, Andrea Ferrari, Stefano Chiaravalli, Gloria Pelizzo, Rita Alaggio +10 morewiley +1 more sourceMilestone Review: Unlocking the Proteomics of Glycine Receptor Complexes
Journal of Neurochemistry, Volume 169, Issue 4, April 2025.Glycine receptors (GlyRs) play key roles in brain development, learning/memory, inflammatory pain sensitization, and rhythmic breathing. GlyRs depend upon stable and transient protein–protein interactions that influence synaptic localization, homeostasis, signaling pathways, and receptor function.Sean D. Fraser, Remco V. Klaassen, Carmen Villmann, August B. Smit, Robert J. Harvey +4 morewiley +1 more sourceThe Harmonious Soul and the Defence of Music in Sixteenth‐Century England
Renaissance Studies, Volume 39, Issue 2, Page 201-215, April 2025.Abstract
This article examines the history of the concept of the soul as a harmony—as opposed to merely being like a harmony—in sixteenth‐century England, demonstrating how debates over music's morality in sixteenth‐century England were a catalyst for theorising an increasing affinity between music and the soul.Katherine Butlerwiley +1 more sourceClassic Methodologies: Why They Still Matter
New Directions for Evaluation, Volume 2025, Issue 185-186, Page 65-72, Spring-Summer 2025.ABSTRACT
While recognizing the importance of innovative, new approaches to evaluation, the guest editors and authors present this special issue of New Directions for Evaluation, urging evaluators to revisit established methodologies to address the growing complexity and ambiguity of today's wicked problems and indeed any problem they are commissioned ...Benjamin Harris, Julianne Kealeywiley +1 more sourceGiving Journeys: The Role of Private Foundations
Nonprofit Management and Leadership, Volume 35, Issue 3, Page 593-605, Spring 2025.ABSTRACT
The giving journeys of individuals, relating to their life stories and life places, have been positioned in the literature as romanticized versions of self. This research adopts a theory of philanthropic identity narratives using a journey metaphor, and explores the role and journeys associated with establishing a giving structure in the form ...Alexandra Williamson, Belinda Lukewiley +1 more sourceSigns of the sacred at the sanctuary of Gravisca, Italy: reconstruction of an Etruscan ritual through a multidisciplinary approach
Archaeometry, Volume 67, Issue 1, Page 235-247, February 2025.Abstract
Archaeological campaigns carried out at the emporic sanctuary of Gravisca (Tarquinia, Italy) have revealed extraordinary evidence for ritual depositions and ceremonies linked to the divinities/guarantors of the sanctuary. The ritual of one such deposition was reconstructed using a multidisciplinary approach, comprising an in‐depth analysis of ...Giulia Patrizi, Maxime Rageot, Sara Cafisso, Antonio Pennetta, Lucio Fiorini, Giuseppe Egidio De Benedetto, Cynthianne Spiteri, Girolamo Fiorentino +7 morewiley +1 more sourceRacial Disparities and Achievement of the Low Lupus Disease Activity State: A CARRA Registry Study
Arthritis Care &Research, Volume 77, Issue 1, Page 38-49, January 2025.Objective
Differential disease control may contribute to racial disparities in outcomes of childhood‐onset systemic lupus erythematosus (cSLE). We evaluated associations of race and individual‐ or neighborhood‐level social determinants of health (SDoH) with achievement of low lupus disease activity state (LLDAS), a clinically relevant treatment target. William Daniel Soulsby, Rebecca Olveda, Jie He, Laura Berbert, Edie Weller, Kamil E. Barbour, Kurt J. Greenlund, Laura E. Schanberg, Emily von Scheven, Aimee Hersh, Mary Beth F. Son, Joyce Chang, Andrea Knight, on behalf of the CARRA Registry Investigators, R. Aamir, K. Abulaban, A. Adams, C. Aguiar Lapsia, A. Akinsete, S. Akoghlanian, M. Al Manaa, A. AlBijadi, E. Allenspach, A. Almutairi, R. Alperin, G. Amarilyo, W. Ambler, M. Amoruso, S. Angeles‐Han, S. Ardoin, S. Armendariz, L. Asfaw, N. Aviran Dagan, C. Bacha, I. Balboni, S. Balevic, S. Ballinger, S. Baluta, L. Barillas‐Arias, M. Basiaga, K. Baszis, S. Baxter, M. Becker, A. Begezda, E. Behrens, E. Beil, S. Benseler, L. Bermudez‐Santiago, W. Bernal, T. Bigley, C. Bingham, B. Binstadt, C. Black, B. Blackmon, M. Blakley, J. Bohnsack, A. Boneparth, H. Bradfield, J. Bridges, E. Brooks, M. Brothers, H. Brunner, L. Buckley, M. Buckley, M. Buckley, H. Bukulmez, D. Bullock, S. Canna, L. Cannon, S. Canny, V. Cartwright, E. Cassidy, D. Castro, E. Chalom, J. Chang, M. Chang, J. Chang, A. Chang‐Hoftman, A. Chen, P. Chiraseveenuprapund, K. Ciaglia, D. Co, E. Cohen, J. Collinge, H. Conlon, R. Connor, K. Cook, A. Cooper, J. Cooper, K. Corbin, C. Correll, R. Cron, M. Curry, A. Dalrymple, E. Datyner, T. Davis, D. De Ranieri, J. Dean, C. DeCoste, F. Dedeoglu, M. DeGuzman, N. Delnay, E. DeSantis, R. Devine, M. Dhalla, A. Dhanrajani, D. Dissanayake, B. Dizon, N. Drapeau, J. Drew, K. Driest, Q. Du, E. Duncan, K. Dunnock, D. Durkee, J. Dvergsten, A. Eberhard, K. Ede, B. Edelheit, C. Edens, T. El Tal, M. Elder, Y. Elzaki, S. Fadrhonc, C. Failing, D. Fair, L. Favier, B. Feldman, J. Fennell, P. Ferguson, I. Ferguson, C. Figueroa, E. Flanagan, L. Fogel, E. Fox, M. Fox, L. Franklin, R. Fuhlbrigge, J. Fuller, M. Furey, T. Futch‐West, S. Gagne, V. Gennaro, D. Gerstbacher, M. Gilbert, A. Gironella, D. Glaser, I. Goh, D. Goldsmith, S. Gorry, N. Goswami, B. Gottlieb, T. Graham, S. Grevich, T. Griffin, A. Grim, A. Grom, M. Guevara, T. Hahn, O. Halyabar, M. Hamda Natur, E. Hammelev, T. Hammond, L. Harel, J. Harris, O. Harry, J. Hausmann, A. Hay, K. Hays, K. Hayward, L. Henderson, M. Henrickson, A. Hersh, K. Hickey, L. Hiraki, M. Hiskey, P. Hobday, C. Hoffart, M. Holland, M. Hollander, S. Hong, D. Horton, M. Horwitz, J. Hsu, A. Huber, A. Huberts, J. Huggins, L. Huie, J. Hui‐Yuen, M. Ibarra, A. Imlay, L. Imundo, C. Inman, A. Jackson, K. James, G. Janow, S. Jared, Y. Jiang, L. Johnson, N. Johnson, J. Jones, D. Kafisheh, P. Kahn, K. Kaidar, S. Kasinathan, R. Kaur, E. Kessler, B. Kienzle, S. Kim, Y. Kimura, D. Kingsbury, M. Kitcharoensakkul, T. Klausmeier, K. Klein, M. Klein‐Gitelman, A. Knight, L. Kovalick, S. Kramer, C. Kremer, O. Kudas, T. LaFlam, B. Lang, S. Lapidus, B. Lapin, A. Lasky, C. Lawler, E. Lawson, R. Laxer, P. Lee, P. Lee, T. Lee, A. Lee, E. Leisinger, L. Lentini, M. Lerman, Y. Levinsky, D. Levy, S. Li, S. Lieberman, L. Lim, E. Limenis, C. Lin, N. Ling, G. Lionetti, R. Livny, M. Lloyd, M. Lo, A. Long, M. Lopez‐Peña, D. Lovell, N. Luca, S. Lvovich, A. Lytch, M. Ma, A. Machado, J. MacMahon, J. Madison, M. Mannion, C. Manos, L. Mansfield, B. Marston, T. Mason, D. Matchett, L. McAllister, K. McBrearty, J. McColl, D. McCurdy, K. McDaniels, J. McDonald, E. Meidan, E. Mellins, Z. Mian, P. Miettunen, M. Miller, D. Milojevic, R. Mitacek, R. Modica, S. Mohan, T. Moore, K. Moore, L. Moorthy, J. Moreno, E. Morgan, A. Moyer, B. Murante, A. Murphy, E. Muscal, O. Mwizerwa, A. Najafi, K. Nanda, N. Nasah, L. Nassi, S. Nativ, M. Natter, K. Nearanz, J. Neely, L. Newhall, A. Nguyen, P. Nigrovic, J. Nocton, B. Nolan, K. Nowicki, R. Oakes, E. Oberle, S. Ogbonnaya‐Whittesley, E. Ogbu, M. Oliver, R. Olveda, K. Onel, A. Orandi, J. Padam, A. Paller, N. Pan, J. Pandya, S. Panupattanapong, A. Pappo Toledano, A. Parsons, J. Patel, P. Patel, A. Patrick, S. Patrizi, S. Paul, J. Perfetto, M. Perron, M. Peskin, L. Ponder, R. Pooni, S. Prahalad, B. Puplava, M. Quinlan‐Waters, C. Rabinovich, J. Rafko, H. Rahimi, K. Rampone, S. Ramsey, R. Randell, L. Ray, A. Reed, A. Reed, H. Reid, D. Reiff, S. Richins, M. Riebschleger, E. Rife, M. Riordan, M. Riskalla, A. Robinson, L. Robinson, L. Rodgers, M. Rodriquez, D. Rogers, T. Ronis, A. Rosado, M. Rosenkranz, N. Rosenwasser, H. Rothermel, D. Rothman, E. Rothschild, E. Roth‐Wojcicki, K. Rouster‐Stevens, T. Rubinstein, J. Rupp, N. Ruth, S. Sabbagh, R. Sadun, L. Santiago, V. Saper, A. Sarkissian, L. Scalzi, J. Schahn, K. Schikler, A. Schlefman, H. Schmeling, E. Schmitt, R. Schneider, G. Schulert, K. Schultz, C. Schutt, C. Seper, R. Sheets, A. Shehab, S. Shenoi, M. Sherman, J. Shirley, M. Shishov, D. Siegel, N. Singer, V. Sivaraman, E. Sloan, C. Smith, J. Smith, E. Smitherman, J. Soep, Mary B. Son, D. Sosna, C. Spencer, L. Spiegel, J. Spitznagle, H. Srinivasalu, H. Stapp, K. Steigerwald, A. Stephens, Y. Sterba Rakovchik, S. Stern, B. Stevens, R. Stevenson, K. Stewart, W. Stewart, C. Stingl, M. Stoll, E. Stringer, S. Sule, J. Sullivan, R. Sundel, M. Sutter, C. Swaffar, N. Swayne, R. Syed, T. Symington, G. Syverson, A. Szymanski, S. Taber, R. Tal, A. Tambralli, A. Taneja, T. Tanner, S. Tarvin, L. Tate, A. Taxter, J. Taylor, M. Tesher, T. Thakurdeen, A. Theisen, B. Thomas, L. Thomas, N. Thomas, T. Ting, C. Todd, D. Toib, D. Toib, K. Torok, H. Tory, M. Toth, S. Tse, C. Tsin, J. Twachtman‐Bassett, M. Twilt, T. Valcarcel, R. Valdovinos, A. Vallee, H. Van Mater, S. Vandenbergen, L. Vannoy, C. Varghese, N. Vasquez, P. Vega‐Fernandez, J. Velez, J. Verbsky, R. Verstegen, E. von Scheven, S. Vora, L. Wagner‐Weiner, D. Wahezi, H. Waite, B. Walker, H. Walters, M. Waterfield, A. Waters, P. Weiser, P. Weiss, J. Weiss, E. Wershba, V. Westheuser, A. White, K. Widrick, C. Williams, S. Wong, L. Woolnough, T. Wright, E. Wu, A. Yalcindag, S. Yasin, R. Yeung, K. Yomogida, A. Zeft, Y. Zhang, Y. Zhao, A. Zhu +487 morewiley +1 more source